Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCND1 | P24385 | 18/20 | 0.41 |
| ▸ | CDK6 | Q00534 | 7/20 | 0.41 |
| ▸ | CDK2 | P24941 | 7/20 | 0.41 |
| ▸ | CCNE1 | P24864 | 4/20 | 0.41 |
| ▸ | CDK4 | P11802 | 18/20 | 0.40 |
| ▸ | CCND3 | P30281 | 14/20 | 0.40 |
| ▸ | CCND2 | P30279 | 10/20 | 0.37 |
| ▸ | CCNA2 | P20248 | 4/20 | 0.35 |
| ▸ | CDK1 | P06493 | 2/20 | 0.34 |
| ▸ | CCNA1 | P78396 | 2/20 | 0.34 |
| ▸ | CCNB2 | O95067 | 1/20 | 0.34 |
| ▸ | CCNE2 | O96020 | 1/20 | 0.34 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.34 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.34 |
| ▸ | FGFR2 | P21802 | 1/20 | 0.34 |
| ▸ | FGFR4 | P22455 | 1/20 | 0.34 |
| ▸ | FGFR3 | P22607 | 1/20 | 0.34 |
| ▸ | CCNB3 | Q8WWL7 | 1/20 | 0.34 |
| ▸ | CCNT1 | O60563 | 1/20 | 0.32 |
| ▸ | CDK9 | P50750 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22553590 | 1.00 | CCND1 (0.41) | CCND1CDK6CDK2CCNE1CDK4 | |
| SCHEMBL22553484 | 0.90 | CCND1 (0.50) | CCND1CDK6CDK2CCNE1CDK4 | |
| SCHEMBL22553482 | 0.90 | CCND1 (0.50) | CCND1CDK6CDK2CCNE1CDK4 | |
| SCHEMBL22553571 | 0.84 | CCND1 (0.44) | CCND1CDK6CDK2CCNE1CDK4 | |
| SCHEMBL22553570 | 0.84 | CCND1 (0.44) | CCND1CDK6CDK2CCNE1CDK4 | |
| SCHEMBL22553576 | 0.84 | CCND1 (0.37) | CCND1CDK6CDK2CCNE1CDK4 | |
| SCHEMBL22553575 | 0.84 | CCND1 (0.37) | CCND1CDK6CDK2CCNE1CDK4 | |
| SCHEMBL22553604 | 0.83 | CCND1 (0.46) | CCND1CDK6CDK2CCNE1CDK4 | |
| SCHEMBL22553458 | 0.83 | CCND1 (0.46) | CCND1CDK6CDK2CCNE1CDK4 | |
| SCHEMBL28687330 | 0.82 | CCND1 (0.37) | CCND1CDK6CDK2CCNE1CDK4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11203594-B2 | Anti-proliferative agents for treating PAH | PFIZER INC. (US) | 2021-12-21 | — | — | US | disclosed |
| US-20200331909-A1 | ANTI-PROLIFERATIVE AGENTS FOR TREATING PAH | PFIZER INC. (US) | 2020-10-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11203594-B2 | Anti-proliferative agents for treating PAH | EDNRB, EDNRA, PAH | CCND1 108/4885CDK6 335/4885CDK2 286/4885 |
| US-20200331909-A1 | ANTI-PROLIFERATIVE AGENTS FOR TREATING PAH | EDNRB, EDNRA, PAH | CCND1 108/4885CDK6 335/4885CDK2 286/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.